{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:57:03Z","timestamp":1785268623814,"version":"3.55.0"},"reference-count":170,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CVP"],"published-print":{"date-parts":[[2020,12,4]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Adverse innate immune responses have been implicated in several disease processes, including\ncardiovascular disease (CVD) and chronic kidney disease (CKD). The monocyte subsets natural\nkiller (NK) cells and natural killer T (NKT) cells are involved in innate immunity. Monocytes subsets\nare key in atherogenesis and the inflammatory cascade occurring in heart failure. Upregulated activity\nand counts of proinflammatory CD16+ monocyte subsets are associated with clinical indices of atherosclerosis,\nheart failure syndromes and CKD. Advanced CKD is a complex state of persistent systemic\ninflammation characterized by elevated expression of proinflammatory and pro-atherogenic\nCD14++CD16+ monocytes, which are associated with cardiovascular events and death both in the general\npopulation and among patients with CKD. Diminished NK cells and NKT cells counts and aberrant\nactivity are observed in both coronary artery disease and end-stage kidney disease. However, evidence\nof the roles of NK cells and NKT cells in atherogenesis in advanced CKD is circumstantial and remains\nto be clarified. This review describes the available evidence regarding the roles of specific immune cell\nsubsets in the pathogenesis of CVD in patients with CKD. Future research is expected to further uncover\nthe links between CKD associated innate immune system dysregulation and accelerated CVD and\nwill ideally be translated into therapeutic targets.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570161118666200628024027","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T06:18:28Z","timestamp":1593497908000},"page":"63-76","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Innate Immune System and Cardiovascular Disease in ESKD: Monocytes and Natural Killer Cells"],"prefix":"10.2174","volume":"19","author":[{"given":"Evangelia","family":"Dounousi","sequence":"first","affiliation":[{"name":"Department of Nephrology, Medical School, University of Ioannina, Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anila","family":"Duni","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Medical School, University of Ioannina, Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina K.","family":"Naka","sequence":"additional","affiliation":[{"name":"2nd Department of Cardiology, Medical School, University of Ioannina, Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Vartholomatos","sequence":"additional","affiliation":[{"name":"Laboratory of Haematology - Unit of Molecular Biology, University Hospital of Ioannina, Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Zoccali","sequence":"additional","affiliation":[{"name":"Institute of Clinical Physiology-Reggio Cal Unit, National Research Council, Reggio Calabria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/nri2686","volume":"10","author":"Cooper M.D.","year":"2010","unstructured":"Cooper M.D.; Herrin B.R.; How did our complex immune system evolve? Nat Rev Immunol 2010,10(1),2-3","journal-title":"Nat Rev Immunol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.2215\/CJN.04680514","volume":"10","author":"Hato T.","year":"2015","unstructured":"Hato T.; Dagher P.C.; How the innate immune system senses trouble and causes trouble. Clin J Am Soc Nephrol 2015,10(8),1459-1469","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3389\/fimmu.2019.00680","volume":"10","author":"Okeke E.B.","year":"2019","unstructured":"Okeke E.B.; Uzonna J.E.; The pivotal role of regulatory t cells in the regulation of innate immune cells. Front Immunol 2019,10,680","journal-title":"Front Immunol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nri3800","volume":"15","author":"Epelman S.","year":"2015","unstructured":"Epelman S.; Liu P.P.; Mann D.L.; Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nat Rev Immunol 2015,15(2),117-129","journal-title":"Nat Rev Immunol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1001\/jama.2009.1488","volume":"302","author":"de Jager D.J.","year":"2009","unstructured":"de Jager D.J.; Grootendorst D.C.; Jager K.J.; Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009,302(16),1782-1789","journal-title":"JAMA"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1681\/ASN.2004110972","volume":"16","author":"Tripepi G.","year":"2005","unstructured":"Tripepi G.; Mallamaci F.; Zoccali C.; Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. J Am Soc Nephrol 2005,16(Suppl. 1),S83-S88","journal-title":"J Am Soc Nephrol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.2215\/CJN.03500412","volume":"7","author":"Gupta J.","year":"2012","unstructured":"Gupta J.; Mitra N.; Kanetsky P.A.; Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol 2012,7(12),1938-1946","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/sj.ki.5000417","volume":"70","author":"Zoccali C.","year":"2006","unstructured":"Zoccali C.; Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. Kidney Int 2006,70(1),26-33","journal-title":"Kidney Int"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/cei.13119","volume":"192","author":"Tecklenborg J.","year":"2018","unstructured":"Tecklenborg J.; Clayton D.; Siebert S.; Coley S.M.; The role of the immune system in kidney disease. Clin Exp Immunol 2018,192(2),142-150","journal-title":"Clin Exp Immunol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1586\/14779072.6.7.987","volume":"6","author":"Meier P.","year":"2008","unstructured":"Meier P.; Meier R.; Blanc E.; Influence of CD4+\/CD25+ regulatory T cells on atherogenesis in patients with end-stage kidney disease. Expert Rev Cardiovasc Ther 2008,6(7),987-997","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.kint.2016.03.022","volume":"90","author":"Hu M.","year":"2016","unstructured":"Hu M.; Wang Y.M.; Wang Y.; Regulatory T cells in kidney disease and transplantation. Kidney Int 2016,90(3),502-514","journal-title":"Kidney Int"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1182\/blood.V74.7.2527.2527","volume":"74","author":"Passlick B.","year":"1989","unstructured":"Passlick B.; Flieger D.; Ziegler-Heitbrock H.W.; Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989,74(7),2527-2534","journal-title":"Blood"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1126\/science.1698311","volume":"249","author":"Wright S.D.","year":"1990","unstructured":"Wright S.D.; Ramos R.A.; Tobias P.S.; Ulevitch R.J.; Mathison J.C.; CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990,249(4975),1431-1433","journal-title":"Science"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1084\/jem.167.2.408","volume":"167","author":"Clarkson S.B.","year":"1988","unstructured":"Clarkson S.B.; Ory P.A.; CD16. Developmentally regulated IgG Fc receptors on cultured human monocytes. J Exp Med 1988,167(2),408-420","journal-title":"J Exp Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1182\/blood-2011-01-326827","volume":"118","author":"Zawada A.M.","year":"2011","unstructured":"Zawada A.M.; Rogacev K.S.; Rotter B.; Super SAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood 2011,118(12),e50-e61","journal-title":"Blood"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","volume":"116","author":"Ziegler-Heitbrock L.","year":"2010","unstructured":"Ziegler-Heitbrock L.; Ancuta P.; Crowe S.; Nomenclature of monocytes and dendritic cells in blood. Blood 2010,116(16),e74-e80","journal-title":"Blood"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1182\/blood-2010-12-326355","volume":"118","author":"Wong K.L.","year":"2011","unstructured":"Wong K.L.; Tai J.J.; Wong W.C.; Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 2011,118(5),e16-e31","journal-title":"Blood"},{"key":"ref=18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176460","volume":"12","author":"Boyette L.B.","year":"2017","unstructured":"Boyette L.B.; Macedo C.; Hadi K.; Phenotype, function, and differentiation potential of human monocyte subsets. PLoS One 2017,12(4)","journal-title":"PLoS One"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40169-014-0040-3","volume":"4","author":"Stansfield B.K.","year":"2015","unstructured":"Stansfield B.K.; Ingram D.A.; Clinical significance of monocyte heterogeneity. Clin Transl Med 2015,4,5","journal-title":"Clin Transl Med"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.4049\/jimmunol.168.7.3536","volume":"168","author":"Belge K.U.","year":"2002","unstructured":"Belge K.U.; Dayyani F.; Horelt A.; The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol 2002,168(7),3536-3542","journal-title":"J Immunol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1172\/JCI28549","volume":"117","author":"Tacke F.","year":"2007","unstructured":"Tacke F.; Alvarez D.; Kaplan T.J.; Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 2007,117(1),185-194","journal-title":"J Clin Invest"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1096\/fj.08-118240","volume":"23","author":"Mosig S.","year":"2009","unstructured":"Mosig S.; Rennert K.; Krause S.; Different functions of monocyte subsets in familial hypercholesterolemia: potential function of CD14+ CD16+ monocytes in detoxification of oxidized LDL. FASEB J 2009,23(3),866-874","journal-title":"FASEB J"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12865-014-0050-3","volume":"15","author":"Schauer D.","year":"2014","unstructured":"Schauer D.; Starlinger P.; Zajc P.; Monocytes with angiogenic potential are selectively induced by liver resection and accumulate near the site of liver regeneration. BMC Immunol 2014,15,50","journal-title":"BMC Immunol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/cvr\/cvw223","volume":"113","author":"Fujisawa T.","year":"2017","unstructured":"Fujisawa T.; Wang K.; Niu X.L.; Angiopoietin-1 promotes atherosclerosis by increasing the proportion of circulating Gr1+ monocytes. Cardiovasc Res 2017,113(1),81-89","journal-title":"Cardiovasc Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1161\/CIRCRESAHA.117.310739","volume":"120","author":"Quintar A.","year":"2017","unstructured":"Quintar A.; McArdle S.; Wolf D.; Endothelial protective monocyte patrolling in large arteries intensified by western diet and ather-osclerosis. Circ Res 2017,120(11),1789-1799","journal-title":"Circ Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fcvm.2017.00080","volume":"19","author":"Buscher K.","year":"2017","unstructured":"Buscher K.; Marcovecchio P.; Hedrick C.C.; Patrolling mechanics of nonclassical monocytes in vascular inflammation. Front Cardiovasc Med 2017,19,80","journal-title":"Front Cardiovasc Med"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrcardio.2009.228","volume":"7","author":"Woollard K.J.","year":"2010","unstructured":"Woollard K.J.; Geissmann F.; Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol 2010,7(2),77-86","journal-title":"Nat Rev Cardiol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1161\/CIRCGENETICS.111.962647","volume":"5","author":"Mehta N.N.","year":"2012","unstructured":"Mehta N.N.; Reilly M.P.; Monocyte mayhem: do subtypes modulate distinct atherosclerosis phenotypes? Circ Cardiovasc Genet 2012,5(1),7-9","journal-title":"Circ Cardiovasc Genet"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.ehj.2004.05.002","volume":"25","author":"Wheeler J.G.","year":"2004","unstructured":"Wheeler J.G.; Mussolino M.E.; Gillum R.F.; Danesh J.; Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individuals. Eur Heart J 2004,25(15),1287-1292","journal-title":"Eur Heart J"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1161\/01.ATV.16.12.1437","volume":"16","author":"Rothe G.","year":"1996","unstructured":"Rothe G.; Gabriel H.; Kovacs E.; Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. Arterioscler Thromb Vasc Biol 1996,16(12),1437-1447","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.atherosclerosis.2013.05.011","volume":"229","author":"Estruch M.","year":"2013","unstructured":"Estruch M.; Bancells C.; Beloki L.; Sanchez-Quesada J.L.; Ord\u00f3\u00f1ez-Llanos J.; Benitez S.; CD14 and TLR4 mediate cytokine release promoted by electronegative LDL in monocytes. Atherosclerosis 2013,229(2),356-362","journal-title":"Atherosclerosis"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1161\/ATVBAHA.111.230979","volume":"31","author":"Poitou C.","year":"2011","unstructured":"Poitou C.; Dalmas E.; Renovato M.; CD14dimCD16+ and CD14+CD16+ monocytes in obesity and during weight loss: relationships with fat mass and subclinical atherosclerosis. Arterioscler Thromb Vasc Biol 2011,31(10),2322-2330","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/eurheartj\/ehp308","volume":"31","author":"Rogacev K.S.","year":"2010","unstructured":"Rogacev K.S.; Ulrich C.; Bl\u00f6mer L.; Monocyte heterogeneity in obesity and subclinical atherosclerosis. Eur Heart J 2010,31(3),369-376","journal-title":"Eur Heart J"},{"key":"ref=34","first-page":"11","volume":"101","author":"Huang Z.S.","year":"2002","unstructured":"Huang Z.S.; Chiang B.L.; Correlation between serum lipid profiles and the ratio and count of the CD16+ monocyte subset in peripheral blood of apparently healthy adults. J Formos Med Assoc 2002,101(1),11-17","journal-title":"J Formos Med Assoc"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.atherosclerosis.2010.05.004","volume":"212","author":"Kashiwagi M.","year":"2010","unstructured":"Kashiwagi M.; Imanishi T.; Tsujioka H.; Association of monocyte subsets with vulnerability characteristics of coronary plaques as assessed by 64-slice multidetector computed tomography in patients with stable angina pectoris. Atherosclerosis 2010,212(1),171-176","journal-title":"Atherosclerosis"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.metabol.2010.05.002","volume":"59","author":"Coen P.M.","year":"2010","unstructured":"Coen P.M.; Flynn M.G.; Markofski M.M.; Pence B.D.; Hannemann R.E.; Adding exercise to rosuvastatin treatment: influence on C-reactive protein, monocyte toll-like receptor 4 expression, and inflammatory monocyte (CD14+CD16+) population. Metabolism 2010,59(12),1775-1783","journal-title":"Metabolism"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.atherosclerosis.2010.06.025","volume":"212","author":"Imanishi T.","year":"2010","unstructured":"Imanishi T.; Ikejima H.; Tsujioka H.; Association of monocyte subset counts with coronary fibrous cap thickness in patients with unstable angina pectoris. Atherosclerosis 2010,212(2),628-635","journal-title":"Atherosclerosis"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1084\/jem.20070885","volume":"204","author":"Nahrendorf M.","year":"2007","unstructured":"Nahrendorf M.; Swirski F.K.; Aikawa E.; The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007,204(12),3037-3047","journal-title":"J Exp Med"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jacc.2009.04.021","volume":"54","author":"Tsujioka H.","year":"2009","unstructured":"Tsujioka H.; Imanishi T.; Ikejima H.; Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. J Am Coll Cardiol 2009,54(2),130-138","journal-title":"J Am Coll Cardiol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/MCA.0b013e32834df5b3","volume":"23","author":"Arslan U.","year":"2012","unstructured":"Arslan U.; Kocao\u011flu \u0130.; Falay M.Y.; Balc\u0131 M.; Duyuler S.; Korkmaz A.; The association between different monocyte subsets and coronary collateral development. Coron Artery Dis 2012,23(1),16-21","journal-title":"Coron Artery Dis"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1253\/circj.CJ-09-1045","volume":"74","author":"Tsujioka H.","year":"2010","unstructured":"Tsujioka H.; Imanishi T.; Ikejima H.; Post-reperfusion enhancement of CD14(+)CD16(-) monocytes and microvascular obstruction in ST-segment elevation acute myocardial infarction. Circ J 2010,74(6),1175-1182","journal-title":"Circ J"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ahj.2011.09.002","volume":"163","author":"van der Laan A.M.","year":"2012","unstructured":"van der Laan A.M.; Hirsch A.; Robbers L.F.; A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: monocytes and myocardial infarction. Am Heart J 2012,163(1),57-65","journal-title":"Am Heart J"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1253\/circj.CJ-12-0006","volume":"76","author":"Ozaki Y.","year":"2012","unstructured":"Ozaki Y.; Imanishi T.; Tanimoto T.; Effect of direct renin inhibitor, aliskiren, on peripheral blood monocyte subsets and myocardial salvage in patients with primary acute myocardial infarction. Circ J 2012,76(6),1461-1468","journal-title":"Circ J"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1126\/science.1175202","volume":"325","author":"Swirski F.K.","year":"2009","unstructured":"Swirski F.K.; Nahrendorf M.; Etzrodt M.; Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009,325(5940),612-616","journal-title":"Science"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1111\/j.1538-7836.2011.04603.x","volume":"10","author":"Tapp L.D.","year":"2012","unstructured":"Tapp L.D.; Shantsila E.; Wrigley B.J.; Pamukcu B.; Lip G.Y.; The CD14++CD16+ monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction. J Thromb Haemost 2012,10(7),1231-1241","journal-title":"J Thromb Haemost"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1161\/CIRCGENETICS.111.960385","volume":"5","author":"Berg K.E.","year":"2012","unstructured":"Berg K.E.; Ljungcrantz I.; Andersson L.; Elevated CD14++CD16- monocytes predict cardiovascular events. Circ Cardiovasc Genet 2012,5(1),122-131","journal-title":"Circ Cardiovasc Genet"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.jacc.2012.07.019","volume":"60","author":"Rogacev K.S.","year":"2012","unstructured":"Rogacev K.S.; Cremers B.; Zawada A.M.; CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography. J Am Coll Cardiol 2012,60(16),1512-1520","journal-title":"J Am Coll Cardiol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1053\/j.ajkd.2009.02.008","volume":"53","author":"Snaedal S.","year":"2009","unstructured":"Snaedal S.; Heimb\u00fcrger O.; Qureshi A.R.; Comorbidity and acute clinical events as determinants of C-reactive protein variation in he-modialysis patients: implications for patient survival. Am J Kidney Dis 2009,53(6),1024-1033","journal-title":"Am J Kidney Dis"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1093\/ndt\/gfm951","volume":"23","author":"Panichi V.","year":"2008","unstructured":"Panichi V.; Rizza G.M.; Paoletti S.; Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study. Nephrol Dial Transplant 2008,23(7),2337-2343","journal-title":"Nephrol Dial Transplant"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1111\/j.1523-1755.2005.00200.x","volume":"67","author":"Stenvinkel P.","year":"2005","unstructured":"Stenvinkel P.; Ketteler M.; Johnson R.J.; IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly. Kidney Int 2005,67(4),1216-1233","journal-title":"Kidney Int"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1093\/ndt\/gfp625","volume":"25","author":"Cohen S.D.","year":"2010","unstructured":"Cohen S.D.; Phillips T.M.; Khetpal P.; Kimmel P.L.; Cytokine patterns and survival in haemodialysis patients. Nephrol Dial Transplant 2010,25(4),1239-1243","journal-title":"Nephrol Dial Transplant"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1159\/000064089","volume":"92","author":"Satomura A.","year":"2002","unstructured":"Satomura A.; Endo M.; Ohi H.; Significant elevations in serum mannose-binding lectin levels in patients with chronic renal failure. Nephron 2002,92(3),702-704","journal-title":"Nephron"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/j.1525-1594.2005.29097.x","volume":"29","author":"Chmielewski M.","year":"2005","unstructured":"Chmielewski M.; Bryl E.; Marzec L.; Aleksandrowicz E.; Witkowski J.M.; Rutkowski B.; Expression of scavenger receptor CD36 in chronic renal failure patients. Artif Organs 2005,29(8),608-614","journal-title":"Artif Organs"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.2215\/CJN.00950208","volume":"3","author":"Kato S.","year":"2008","unstructured":"Kato S.; Chmielewski M.; Honda H.; Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 2008,3(5),1526-1533","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1161\/ATVBAHA.114.304172","volume":"34","author":"Rogacev K.S.","year":"2014","unstructured":"Rogacev K.S.; Zawada A.M.; Emrich I.; Lower Apo A-I and lower HDL-C levels are associated with higher intermediate CD14++CD16+ monocyte counts that predict cardiovascular events in chronic kidney disease. Arterioscler Thromb Vasc Biol 2014,34(9),2120-2127","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/sj.ki.5002019","volume":"71","author":"Yoon J.W.","year":"2007","unstructured":"Yoon J.W.; Pahl M.V.; Vaziri N.D.; Spontaneous leukocyte activation and oxygen-free radical generation in end-stage renal disease. Kidney Int 2007,71(2),167-172","journal-title":"Kidney Int"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"13964","DOI":"10.1038\/s41598-018-31889-2","volume":"8","author":"Liakopoulos V.","year":"2018","unstructured":"Liakopoulos V.; Jeron A.; Shah A.; Bruder D.; Mertens P.R.; Gorny X.; Hemodialysis-related changes in phenotypical features of monocytes. Sci Rep 2018,8(1),13964","journal-title":"Sci Rep"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1007\/s00018-017-2490-4","volume":"74","author":"Finney A.C.","year":"2017","unstructured":"Finney A.C.; Stokes K.Y.; Pattillo C.B.; Orr A.W.; Integrin signaling in atherosclerosis. Cell Mol Life Sci 2017,74(12),2263-2282","journal-title":"Cell Mol Life Sci"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3109\/08830185.2012.706761","volume":"31","author":"Moghimpour Bijani F.","year":"2012","unstructured":"Moghimpour Bijani F.; Vallejo J.G.; Rezaei N.; Toll-like receptor signaling pathways in cardiovascular diseases: challenges and opportunities. Int Rev Immunol 2012,31(5),379-395","journal-title":"Int Rev Immunol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3892\/ijmm.19.5.783","volume":"19","author":"Kuroki Y.","year":"2007","unstructured":"Kuroki Y.; Tsuchida K.; Go I.; A study of innate immunity in patients with end-stage renal disease: special reference to toll-like receptor-2 and -4 expression in peripheral blood monocytes of hemodialysis patients. Int J Mol Med 2007,19(5),783-790","journal-title":"Int J Mol Med"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/ndt\/gfq500","volume":"26","author":"Koc M.","year":"2011","unstructured":"Koc M.; Toprak A.; Arikan H.; Toll-like receptor expression in monocytes in patients with chronic kidney disease and haemodialysis: relation with inflammation. Nephrol Dial Transplant 2011,26(3),955-963","journal-title":"Nephrol Dial Transplant"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/sj.ki.5001548","volume":"70","author":"Ando M.","year":"2006","unstructured":"Ando M.; Shibuya A.; Tsuchiya K.; Akiba T.; Nitta K.; Reduced expression of Toll-like receptor 4 contributes to impaired cytokine response of monocytes in uremic patients. Kidney Int 2006,70(2),358-362","journal-title":"Kidney Int"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000276764","volume":"31","author":"Gollapudi P.","year":"2010","unstructured":"Gollapudi P.; Yoon J.W.; Gollapudi S.; Pahl M.V.; Vaziri N.D.; Leukocyte toll-like receptor expression in end-stage kidney disease. Am J Nephrol 2010,31(3),247-254","journal-title":"Am J Nephrol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1093\/ndt\/gfq758","volume":"26","author":"Lorenzen J.M.","year":"2011","unstructured":"Lorenzen J.M.; David S.; Richter A.; TLR-4+ peripheral blood monocytes and cardiovascular events in patients with chronic kidney disease--a prospective follow-up study. Nephrol Dial Transplant 2011,26(4),1421-1424","journal-title":"Nephrol Dial Transplant"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1161\/CIRCULATIONAHA.107.745091","volume":"117","author":"Combadi\u00e8re C.","year":"2008","unstructured":"Combadi\u00e8re C.; Potteaux S.; Rodero M.; Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) mon-ocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 2008,117(13),1649-1657","journal-title":"Circulation"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1681\/ASN.2008040432","volume":"20","author":"Muntinghe F.L.","year":"2009","unstructured":"Muntinghe F.L.; Verduijn M.; Zuurman M.W.; CCR5 deletion protects against inflammation-associated mortality in dialysis patients. J Am Soc Nephrol 2009,20(7),1641-1649","journal-title":"J Am Soc Nephrol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1744-9987.2009.00658.x","volume":"13","author":"Okumoto S.","year":"2009","unstructured":"Okumoto S.; Taniguchi Y.; Nakashima A.; C-C chemokine receptor 2 expression by circulating monocytes influences atherosclerosis in patients on chronic hemodialysis. Ther Apher Dial 2009,13(3),205-212","journal-title":"Ther Apher Dial"},{"key":"ref=68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121750","volume":"10","author":"Schepers E.","year":"2015","unstructured":"Schepers E.; Houthuys E.; Dhondt A.; Transcriptome analysis in patients with chronic kidney disease on hemodialysis disclosing a key role for CD16+CX3CR1+ monocytes. PLoS One 2015,10(4)","journal-title":"PLoS One"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0021-9150(99)00354-8","volume":"150","author":"Metzger R.","year":"2000","unstructured":"Metzger R.; Bohle R.M.; Chumachenko P.; Danilov S.M.; Franke F.E.; CD143 in the development of atherosclerosis. Atherosclerosis 2000,150(1),21-31","journal-title":"Atherosclerosis"},{"key":"ref=70","first-page":"287","volume":"32","author":"Trojanowicz B.","year":"2017","unstructured":"Trojanowicz B.; Ulrich C.; Kohler F.; Monocytic angiotensin-converting enzyme 2 relates to atherosclerosis in patients with chronic kidney disease. Nephrol Dial Transplant 2017,32(2),287-298","journal-title":"Nephrol Dial Transplant"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1093\/ndt\/gfl008","volume":"21","author":"Ulrich C.","year":"2006","unstructured":"Ulrich C.; Heine G.H.; Garcia P.; Increased expression of monocytic angiotensin-converting enzyme in dialysis patients with cardi-ovascular disease. Nephrol Dial Transplant 2006,21(6),1596-1602","journal-title":"Nephrol Dial Transplant"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2215\/CJN.06870810","volume":"6","author":"Ulrich C.","year":"2011","unstructured":"Ulrich C.; Seibert E.; Heine G.H.; Fliser D.; Girndt M.; Monocyte angiotensin converting enzyme expression may be associated with athero-sclerosis rather than arteriosclerosis in hemodialysis patients. Clin J Am Soc Nephrol 2011,6(3),505-511","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1093\/ndt\/gfq012","volume":"25","author":"Ulrich C.","year":"2010","unstructured":"Ulrich C.; Heine G.H.; Seibert E.; Fliser D.; Girndt M.; Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease. Nephrol Dial Transplant 2010,25(7),2265-2272","journal-title":"Nephrol Dial Transplant"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nrneph.2012.41","volume":"8","author":"Heine G.H.","year":"2012","unstructured":"Heine G.H.; Ortiz A.; Massy Z.A.; European renal and cardiovascular medicine (EURECA m) working group of the European renal association-European dialysis and transplant association (ERA-EDTA). Monocyte subpopulations and cardiovascular risk in chronic kidney disease. Nat Rev Nephrol 2012,8(6),362-369","journal-title":"Nat Rev Nephrol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/sj.ki.5002744","volume":"73","author":"Heine G.H.","year":"2008","unstructured":"Heine G.H.; Ulrich C.; Seibert E.; CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int 2008,73(5),622-629","journal-title":"Kidney Int"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/eurheartj\/ehq371","volume":"32","author":"Rogacev K.S.","year":"2011","unstructured":"Rogacev K.S.; Seiler S.; Zawada A.M.; CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease. Eur Heart J 2011,32(1),84-92","journal-title":"Eur Heart J"},{"key":"ref=77","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1070959","volume":"2017","author":"Jeng Y.","year":"2017","unstructured":"Jeng Y.; Lim P.S.; Wu M.Y.; Proportions of proinflammatory monocytes are important predictors of mortality risk in hemodialysis patients. Mediators Inflamm 2017,2017","journal-title":"Mediators Inflamm"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/1744-9987.12576","volume":"21","author":"de Sequera P.","year":"2017","unstructured":"de Sequera P.; Corchete E.; Bohorquez L.; Residual Renal Function in Hemodialysis and Inflammation. Ther Apher Dial 2017,21(6),592-598","journal-title":"Ther Apher Dial"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12979-018-0131-x","volume":"15","author":"Chiu Y.L.","year":"2018","unstructured":"Chiu Y.L.; Shu K.H.; Yang F.J.; A comprehensive characterization of aggravated aging-related changes in T lymphocytes and monocytes in end-stage renal disease: the iESRD study. Immun Ageing 2018,15,27","journal-title":"Immun Ageing"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1093\/ndt\/16.7.1402","volume":"16","author":"Sester U.","year":"2001","unstructured":"Sester U.; Sester M.; Heine G.; Kaul H.; Girndt M.; K\u00f6hler H.; Strong depletion of CD14(+)CD16(+) monocytes during haemodialysis treatment. Nephrol Dial Transplant 2001,16(7),1402-1408","journal-title":"Nephrol Dial Transplant"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1046\/j.1365-2249.2001.01436.x","volume":"123","author":"Nockher W.A.","year":"2001","unstructured":"Nockher W.A.; Wiemer J.; Scherberich J.E.; Haemodialysis monocytopenia: differential sequestration kinetics of CD14+CD16+ and CD14++ blood monocyte subsets. Clin Exp Immunol 2001,123(1),49-55","journal-title":"Clin Exp Immunol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000046316","volume":"90","author":"Kawanaka N.","year":"2002","unstructured":"Kawanaka N.; Nagake Y.; Yamamura M.; Makino H.; Expression of Fc gamma receptor III (CD16) on monocytes during hemodialysis in patients with chronic renal failure. Nephron 2002,90(1),64-71","journal-title":"Nephron"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1093\/ndt\/gfp287","volume":"24","author":"Rogacev K.S.","year":"2009","unstructured":"Rogacev K.S.; Ziegelin M.; Ulrich C.; Haemodialysis-induced transient CD16+ monocytopenia and cardiovascular outcome. Nephrol Dial Transplant 2009,24(11),3480-3486","journal-title":"Nephrol Dial Transplant"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ki.2014.9","volume":"86","author":"den Hoedt C.H.","year":"2014","unstructured":"den Hoedt C.H.; Bots M.L.; Grooteman M.P.C.; Online hemodiafiltration reduces systemic inflammation compared to low-flux hemo-dialysis. Kidney Int 2014,86(2),423-432","journal-title":"Kidney Int"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1681\/ASN.2006020105","volume":"17","author":"Carracedo J.","year":"2006","unstructured":"Carracedo J.; Merino A.; Nogueras S.; On-line hemodiafiltration reduces the proinflammatory CD14+CD16+ monocyte-derived den-dritic cells: A prospective, crossover study. J Am Soc Nephrol 2006,17(8),2315-2321","journal-title":"J Am Soc Nephrol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000321889","volume":"31","author":"Kim H.W.","year":"2011","unstructured":"Kim H.W.; Yang H.N.; Kim M.G.; Microinflammation in hemodialysis patients is associated with increased CD14 CD16(+) proinflammatory monocytes: possible modification by on-line hemodiafiltration. Blood Purif 2011,31(4),281-288","journal-title":"Blood Purif"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000350611","volume":"35","author":"Ariza F.","year":"2013","unstructured":"Ariza F.; Merino A.; Carracedo J.; Post-dilution high convective transport improves microinflammation and endothelial dysfunction independently of the technique. Blood Purif 2013,35(4),270-278","journal-title":"Blood Purif"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1159\/000494711","volume":"47","author":"Bolasco P.","year":"2019","unstructured":"Bolasco P.; Spiga P.; Arras M.; Murtas S.; La Nasa G.; Could there be haemodynamic stress effects on pro-inflammatory CD14+ CD16+ monocytes during convective-diffusive treatments? A prospective randomized controlled trial. Blood Purif 2019,47(4),385-394","journal-title":"Blood Purif"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2215\/CJN.03260509","volume":"5","author":"Merino A.","year":"2010","unstructured":"Merino A.; Portol\u00e9s J.; Selgas R.; Effect of different dialysis modalities on microinflammatory status and endothelial damage. Clin J Am Soc Nephrol 2010,5(2),227-234","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1600-6143.2008.02386.x","volume":"8","author":"Ulrich C.","year":"2008","unstructured":"Ulrich C.; Heine G.H.; Gerhart M.K.; K\u00f6hler H.; Girndt M.; Proinflammatory CD14+CD16+ monocytes are associated with subclinical ath-erosclerosis in renal transplant patients. Am J Transplant 2008,8(1),103-110","journal-title":"Am J Transplant"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2172-15-4","volume":"15","author":"Sekerkova A.","year":"2014","unstructured":"Sekerkova A.; Krepsova E.; Brabcova E.; CD14+CD16+ and CD14+CD163+ monocyte subpopulations in kidney allograft trans-plantation. BMC Immunol 2014,15,4","journal-title":"BMC Immunol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/ndt\/gfu315","volume":"30","author":"Rogacev K.S.","year":"2015","unstructured":"Rogacev K.S.; Zawada A.M.; Hundsdorfer J.; Immunosuppression and monocyte subsets. Nephrol Dial Transplant 2015,30(1),143-153","journal-title":"Nephrol Dial Transplant"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1093\/eurjhf\/hfr122","volume":"13","author":"Wrigley B.J.","year":"2011","unstructured":"Wrigley B.J.; Lip G.Y.; Shantsila E.; The role of monocytes and inflammation in the pathophysiology of heart failure. Eur J Heart Fail 2011,13(11),1161-1171","journal-title":"Eur J Heart Fail"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s10741-012-9352-9","volume":"18","author":"Vaduganathan M.","year":"2013","unstructured":"Vaduganathan M.; Greene S.J.; Butler J.; The immunological axis in heart failure: importance of the leukocyte differential. Heart Fail Rev 2013,18(6),835-845","journal-title":"Heart Fail Rev"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/ejhf.1138","volume":"20","author":"Frantz S.","year":"2018","unstructured":"Frantz S.; Falcao-Pires I.; Balligand J.L.; The innate immune system in chronic cardiomyopathy: a European society of cardiology (ESC) scientific statement from the working group on myocardial function of the ESC. Eur J Heart Fail 2018,20(3),445-459","journal-title":"Eur J Heart Fail"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1161\/CIRCULATIONAHA.108.802918","volume":"119","author":"Hamid T.","year":"2009","unstructured":"Hamid T.; Gu Y.; Ortines R.V.; Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation. Circulation 2009,119(10),1386-1397","journal-title":"Circulation"},{"key":"ref=97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099495","volume":"9","author":"Putko B.N.","year":"2014","unstructured":"Putko B.N.; Wang Z.; Lo J.; Circulating levels of tumor necrosis factor-alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: evidence for a divergence in pathophysiology. PLoS One Alberta HEART Investigators2014,9(6)","journal-title":"PLoS One"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0735-1097(97)00494-4","volume":"31","author":"Tsutamoto T.","year":"1998","unstructured":"Tsutamoto T.; Hisanaga T.; Wada A.; Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 1998,31(2),391-398","journal-title":"J Am Coll Cardiol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1161\/CIRCRESAHA.116.309001","volume":"119","author":"Sager H.B.","year":"2016","unstructured":"Sager H.B.; Hulsmans M.; Lavine K.J.; Proliferation and recruitment contribute to myocardial macrophage expansion in chronic heart failure. Circ Res 2016,119(7),853-864","journal-title":"Circ Res"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/s41591-018-0059-x","volume":"24","author":"Bajpai G.","year":"2018","unstructured":"Bajpai G.; Schneider C.; Wong N.; The human heart contains distinct macrophage subsets with divergent origins and functions. Nat Med 2018,24(8),1234-1245","journal-title":"Nat Med"},{"key":"ref=101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040763","volume":"7","author":"Ma Y.","year":"2012","unstructured":"Ma Y.; Zhang X.; Bao H.; Toll-like receptor (TLR) 2 and TLR4 differentially regulate doxorubicin induced cardiomyopathy in mice. PLoS One 2012,7(7)","journal-title":"PLoS One"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ijcard.2005.06.023","volume":"109","author":"Satoh M.","year":"2006","unstructured":"Satoh M.; Shimoda Y.; Maesawa C.; Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction. Int J Cardiol 2006,109(2),226-234","journal-title":"Int J Cardiol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/ejhf.445","volume":"18","author":"Unger E.D.","year":"2016","unstructured":"Unger E.D.; Dubin R.F.; Deo R.; Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction. Eur J Heart Fail 2016,18(1),103-112","journal-title":"Eur J Heart Fail"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jacc.2014.05.030","volume":"64","author":"Lindman B.R.","year":"2014","unstructured":"Lindman B.R.; D\u00e1vila-Rom\u00e1n V.G.; Mann D.L.; Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study. J Am Coll Cardiol 2014,64(6),541-549","journal-title":"J Am Coll Cardiol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jchf.2015.10.007","volume":"4","author":"Franssen C.","year":"2016","unstructured":"Franssen C.; Chen S.; Unger A.; Myocardial microvascular inflammatory endothelial activation in heart failure with preserved ejection fraction. JACC Heart Fail 2016,4(4),312-324","journal-title":"JACC Heart Fail"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cardfail.2014.11.004","volume":"21","author":"Glezeva N.","year":"2015","unstructured":"Glezeva N.; Voon V.; Watson C.; Exaggerated inflammation and monocytosis associate with diastolic dysfunction in heart failure with preserved ejection fraction: evidence of M2 macrophage activation in disease pathogenesis. J Card Fail 2015,21(2),167-177","journal-title":"J Card Fail"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","volume":"119","author":"Guti\u00e9rrez O.M.","year":"2009","unstructured":"Guti\u00e9rrez O.M.; Januzzi J.L.; Isakova T.; Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 2009,119(19),2545-2552","journal-title":"Circulation"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.healun.2015.06.007","volume":"34","author":"Richter M.","year":"2015","unstructured":"Richter M.; Lautze H.J.; Walther T.; Braun T.; Kostin S.; Kubin T.; The failing heart is a major source of circulating FGF23 via oncostatin M receptor activation. J Heart Lung Transplant 2015,34(9),1211-1214","journal-title":"J Heart Lung Transplant"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1093\/eurheartj\/ehy085","volume":"39","author":"Wang L.","year":"2018","unstructured":"Wang L.; Zhang Y.L.; Lin Q.Y.; CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration. Eur Heart J 2018,39(20),1818-1831","journal-title":"Eur Heart J"},{"key":"ref=110","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035506","volume":"7","author":"Han Y.L.","year":"2012","unstructured":"Han Y.L.; Li Y.L.; Jia L.X.; Reciprocal interaction between macrophages and T cells stimulates IFN-\u03b3 and MCP-1 production in Ang II-induced cardiac inflammation and fibrosis. PLoS One 2012,7(5)","journal-title":"PLoS One"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/cvr\/cvt258","volume":"101","author":"Wang L.","year":"2014","unstructured":"Wang L.; Li Y.L.; Zhang C.C.; Inhibition of Toll-like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation. Cardiovasc Res 2014,101(3),383-392","journal-title":"Cardiovasc Res"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2215\/CJN.10441015","volume":"11","author":"Sun J.","year":"2016","unstructured":"Sun J.; Axelsson J.; Machowska A.; Biomarkers of cardiovascular disease and mortality risk in patients with advanced CKD. Clin J Am Soc Nephrol 2016,11(7),1163-1172","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000371661","volume":"5","author":"Carlsson A.C.","year":"2015","unstructured":"Carlsson A.C.; Carrero J.J.; Stenvinkel P.; High levels of soluble tumor necrosis factor receptors 1 and 2 and their association with mortality in patients undergoing hemodialysis. Cardiorenal Med 2015,5(2),89-95","journal-title":"Cardiorenal Med"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1093\/ndt\/gfq557","volume":"26","author":"Meuwese C.L.","year":"2011","unstructured":"Meuwese C.L.; Snaedal S.; Halbesma N.; Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-\u03b1 are similarly associated with survival in haemodialysis patients. Nephrol Dial Transplant 2011,26(4),1313-1318","journal-title":"Nephrol Dial Transplant"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"232","DOI":"10.2215\/CJN.07000714","volume":"10","author":"Spoto B.","year":"2015","unstructured":"Spoto B.; Mattace-Raso F.; Sijbrands E.; Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD. Clin J Am Soc Nephrol 2015,10(2),232-240","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1155\/2010\/236405","volume":"28","author":"Barisione C.","year":"2010","unstructured":"Barisione C.; Garibaldi S.; Ghigliotti G.; CD14CD16 monocyte subset levels in heart failure patients. Dis Markers 2010,28(2),115-124","journal-title":"Dis Markers"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/eci.12023","volume":"43","author":"Wrigley B.J.","year":"2013","unstructured":"Wrigley B.J.; Shantsila E.; Tapp L.D.; Lip G.Y.; CD14++CD16+ monocytes in patients with acute ischaemic heart failure. Eur J Clin Invest 2013,43(2),121-130","journal-title":"Eur J Clin Invest"},{"key":"ref=118","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/616384","volume":"2012","author":"Amir O.","year":"2012","unstructured":"Amir O.; Spivak I.; Lavi I.; Changes in the monocytic subsets CD14dimCD16+ and CD14++CD16- in chronic systolic heart failure patients. Mediators Inflamm 2012,2012","journal-title":"Mediators Inflamm"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1159\/000371898","volume":"5","author":"Pastori S.","year":"2015","unstructured":"Pastori S.; Virz\u00ec G.M.; Brocca A.; Cardiorenal syndrome type 1: a defective regulation of monocyte apoptosis induced by proinflammatory and proapoptotic factors. Cardiorenal Med 2015,5(2),105-115","journal-title":"Cardiorenal Med"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000335499","volume":"2","author":"Virz\u00ec G.M.","year":"2012","unstructured":"Virz\u00ec G.M.; Torregrossa R.; Cruz D.N.; Cardiorenal syndrome type 1 may be immunologically mediated: a pilot evaluation of monocyte apoptosis. Cardiorenal Med 2012,2(1),33-42","journal-title":"Cardiorenal Med"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000488949","volume":"8","author":"Breglia A.","year":"2018","unstructured":"Breglia A.; Virz\u00ec G.M.; Pastori S.; Determinants of monocyte apoptosis in cardiorenal syndrome type 1. Cardiorenal Med 2018,8(3),208-216","journal-title":"Cardiorenal Med"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/ehf2.12327","volume":"5","author":"Linhart C.","year":"2018","unstructured":"Linhart C.; Ulrich C.; Greinert D.; Systemic inflammation in acute cardiorenal syndrome: an observational pilot study. ESC Heart Fail 2018,5(5),920-930","journal-title":"ESC Heart Fail"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1161\/CIRCRESAHA.110.227454","volume":"107","author":"Leuschner F.","year":"2010","unstructured":"Leuschner F.; Panizzi P.; Chico-Calero I.; Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction. Circ Res 2010,107(11),1364-1373","journal-title":"Circ Res"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1136\/hrt.2005.071829","volume":"92","author":"Satoh M.","year":"2006","unstructured":"Satoh M.; Ishikawa Y.; Minami Y.; Akatsu T.; Nakamura M.; Eplerenone inhibits tumour necrosis factor alpha shedding process by tumour necrosis factor alpha converting enzyme in monocytes from patients with congestive heart failure. Heart 2006,92(7),979-980","journal-title":"Heart"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.trsl.2006.11.008","volume":"149","author":"Mizuochi Y.","year":"2007","unstructured":"Mizuochi Y.; Okajima K.; Harada N.; Carvedilol, a nonselective beta-blocker, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro. Transl Res 2007,149(4),223-230","journal-title":"Transl Res"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurjhf\/hfn043","volume":"11","author":"Heymans S.","year":"2009","unstructured":"Heymans S.; Hirsch E.; Anker S.D.; Inflammation as a therapeutic target in heart failure? A scientific statement from the translational research committee of the heart failure association of the European Society of Cardiology. Eur J Heart Fail 2009,11(2),119-129","journal-title":"Eur J Heart Fail"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.imbio.2007.10.012","volume":"213","author":"Wilk E.","year":"2008","unstructured":"Wilk E.; Kalippke K.; Buyny S.; Schmidt R.E.; Jacobs R.; New aspects of NK cell subset identification and inference of NK cells\u2019 regulatory capacity by assessing functional and genomic profiles. Immunobiology 2008,213(3-4),271-283","journal-title":"Immunobiology"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1365-2567.2011.03446.x","volume":"133","author":"Fu B.","year":"2011","unstructured":"Fu B.; Wang F.; Sun R.; Ling B.; Tian Z.; Wei H.; CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells. Immunology 2011,133(3),350-359","journal-title":"Immunology"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.4049\/jimmunol.1502570","volume":"196","author":"Michel T.","year":"2016","unstructured":"Michel T.; Poli A.; Cuapio A.; Human CD56bright NK Cells: An Update. J Immunol 2016,196(7),2923-2931","journal-title":"J Immunol"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nri3369","volume":"13","author":"Brennan P.J.","year":"2013","unstructured":"Brennan P.J.; Brigl M.; Brenner M.B.; Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat Rev Immunol 2013,13(2),101-117","journal-title":"Nat Rev Immunol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00441-010-1023-3","volume":"343","author":"Van Kaer L.","year":"2011","unstructured":"Van Kaer L.; Parekh V.V.; Wu L.; Invariant natural killer T cells: bridging innate and adaptive immunity. Cell Tissue Res 2011,343(1),43-55","journal-title":"Cell Tissue Res"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/imm.12635","volume":"149","author":"Lameris R.","year":"2016","unstructured":"Lameris R.; de Bruin R.C.; van Bergen En Henegouwen P.M.; Generation and characterization of CD1d-specific single-domain antibodies with distinct functional features. Immunology 2016,149(1),111-121","journal-title":"Immunology"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/nrcardio.2017.2","volume":"14","author":"Getz G.S.","year":"2017","unstructured":"Getz G.S.; Reardon C.A.; Natural killer T cells in atherosclerosis. Nat Rev Cardiol 2017,14(5),304-314","journal-title":"Nat Rev Cardiol"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/cvr\/cvu016","volume":"102","author":"Selathurai A.","year":"2014","unstructured":"Selathurai A.; Deswaerte V.; Kanellakis P.; Natural killer (NK) cells augment atherosclerosis by cytotoxic-dependent mechanisms. Cardiovasc Res 2014,102(1),128-137","journal-title":"Cardiovasc Res"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1161\/01.ATV.0000124923.95545.2c","volume":"24","author":"Whitman S.C.","year":"2004","unstructured":"Whitman S.C.; Rateri D.L.; Szilvassy S.J.; Yokoyama W.; Daugherty A.; Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice. Arterioscler Thromb Vasc Biol 2004,24(6),1049-1054","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1742-4933-4-3","volume":"4","author":"Hak \u0141.","year":"2007","unstructured":"Hak \u0141.; My\u015bliwska J.; Wi\u0119ckiewicz J.; NK cell compartment in patients with coronary heart disease. Immun Ageing 2007,4,3","journal-title":"Immun Ageing"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.atherosclerosis.2012.02.009","volume":"222","author":"Hou N.","year":"2012","unstructured":"Hou N.; Zhao D.; Liu Y.; Increased expression of T cell immunoglobulin- and mucin domain-containing molecule-3 on natural killer cells in atherogenesis. Atherosclerosis 2012,222(1),67-73","journal-title":"Atherosclerosis"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.atherosclerosis.2014.01.030","volume":"233","author":"Szymanowski A.","year":"2014","unstructured":"Szymanowski A.; Li W.; Lundberg A.; Soluble Fas ligand is associated with natural killer cell dynamics in coronary artery disease. Atherosclerosis 2014,233(2),616-622","journal-title":"Atherosclerosis"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.atherosclerosis.2005.03.011","volume":"183","author":"Jonasson L.","year":"2005","unstructured":"Jonasson L.; Backteman K.; Ernerudh J.; Loss of natural killer cell activity in patients with coronary artery disease. Atherosclerosis 2005,183(2),316-321","journal-title":"Atherosclerosis"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.atherosclerosis.2007.10.031","volume":"199","author":"Li W.","year":"2008","unstructured":"Li W.; Lidebjer C.; Yuan X.M.; NK cell apoptosis in coronary artery disease: relation to oxidative stress. Atherosclerosis 2008,199(1),65-72","journal-title":"Atherosclerosis"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/cei.12210","volume":"175","author":"Backteman K.","year":"2014","unstructured":"Backteman K.; Ernerudh J.; Jonasson L.; Natural killer (NK) cell deficit in coronary artery disease: no aberrations in phenotype but sustained reduction of NK cells is associated with low-grade inflammation. Clin Exp Immunol 2014,175(1),104-112","journal-title":"Clin Exp Immunol"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12967-015-0564-3","volume":"13","author":"Zuo J.","year":"2015","unstructured":"Zuo J.; Shan Z.; Zhou L.; Yu J.; Liu X.; Gao Y.; Increased CD160 expression on circulating natural killer cells in atherogenesis. J Transl Med 2015,13,188","journal-title":"J Transl Med"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.amjcard.2003.12.054","volume":"93","author":"Vredevoe D.L.","year":"2004","unstructured":"Vredevoe D.L.; Widawski M.; Fonarow G.C.; Hamilton M.; Mart\u00ednez-Maza O.; Gage J.R.; Interleukin-6 (IL-6) expression and natural killer (NK) cell dysfunction and anergy in heart failure. Am J Cardiol 2004,93(8),1007-1011","journal-title":"Am J Cardiol"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.ajpath.2014.11.023","volume":"185","author":"Ong S.","year":"2015","unstructured":"Ong S.; Ligons D.L.; Barin J.G.; Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration. Am J Pathol 2015,185(3),847-861","journal-title":"Am J Pathol"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/cvr\/cvu208","volume":"104","author":"Boukouaci W.","year":"2014","unstructured":"Boukouaci W.; Lauden L.; Siewiera J.; Natural killer cell crosstalk with allogeneic human cardiac-derived stem\/progenitor cells controls persistence. Cardiovasc Res 2014,104(2),290-302","journal-title":"Cardiovasc Res"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejphar.2017.03.052","volume":"816","author":"van Puijvelde G.H.M.","year":"2017","unstructured":"van Puijvelde G.H.M.; Kuiper J.; NKT cells in cardiovascular diseases. Eur J Pharmacol 2017,816,47-57","journal-title":"Eur J Pharmacol"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1161\/CIRCRESAHA.117.304611","volume":"117","author":"Cochain C.","year":"2015","unstructured":"Cochain C.; Koch M.; Chaudhari S.M.; Cd8+ t cells regulate monopoiesis and circulating ly6c-high monocyte levels in atherosclerosis in mice. Circ Res 2015,117(3),244-253","journal-title":"Circ Res"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1161\/01.ATV.0000153046.59370.13","volume":"25","author":"Aslanian A.M.","year":"2005","unstructured":"Aslanian A.M.; Chapman H.A.; Charo I.F.; Transient role for CD1d-restricted natural killer T cells in the formation of atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2005,25(3),628-632","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1161\/CIRCRESAHA.107.160705","volume":"101","author":"Str\u00f6m A.","year":"2007","unstructured":"Str\u00f6m A.; Wigren M.; Hultg\u00e5rdh-Nilsson A.; Involvement of the CD1d-natural killer T cell pathway in neointima formation after vas-cular injury. Circ Res 2007,101(8),e83-e89","journal-title":"Circ Res"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1002\/eji.201040619","volume":"40","author":"Kyriakakis E.","year":"2010","unstructured":"Kyriakakis E.; Cavallari M.; Andert J.; Invariant natural killer T cells: linking inflammation and neovascularization in human athero-sclerosis. Eur J Immunol 2010,40(11),3268-3279","journal-title":"Eur J Immunol"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1161\/ATVBAHA.108.182592","volume":"29","author":"To K.","year":"2009","unstructured":"To K.; Agrotis A.; Besra G.; Bobik A.; Toh B.H.; NKT cell subsets mediate differential proatherogenic effects in ApoE-\/- mice. Arterioscler Thromb Vasc Biol 2009,29(5),671-677","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/cvr\/cvn005","volume":"78","author":"Rogers L.","year":"2008","unstructured":"Rogers L.; Burchat S.; Gage J.; Deficiency of invariant V alpha 14 natural killer T cells decreases atherosclerosis in LDL receptor null mice. Cardiovasc Res 2008,78(1),167-174","journal-title":"Cardiovasc Res"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1161\/CIRCRESAHA.116.304734","volume":"116","author":"Li Y.","year":"2015","unstructured":"Li Y.; To K.; Kanellakis P.; CD4+ natural killer T cells potently augment aortic root atherosclerosis by perforin- and granzyme B-dependent cytotoxicity. Circ Res 2015,116(2),245-254","journal-title":"Circ Res"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1161\/CIRCULATIONAHA.112.001347","volume":"127","author":"Kyaw T.","year":"2013","unstructured":"Kyaw T.; Winship A.; Tay C.; Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice. Circulation 2013,127(9),1028-1039","journal-title":"Circulation"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1160\/TH09-01-0020","volume":"102","author":"van Puijvelde G.H.","year":"2009","unstructured":"van Puijvelde G.H.; van Wanrooij E.J.; Hauer A.D.; de Vos P.; van Berkel T.J.; Kuiper J.; Effect of natural killer T cell activation on the initiation of atherosclerosis. Thromb Haemost 2009,102(2),223-230","journal-title":"Thromb Haemost"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1194\/jlr.M041020","volume":"54","author":"Subramanian S.","year":"2013","unstructured":"Subramanian S.; Turner M.S.; Ding Y.; Increased levels of invariant natural killer T lymphocytes worsen metabolic abnormalities and atherosclerosis in obese mice. J Lipid Res 2013,54(10),2831-2841","journal-title":"J Lipid Res"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/00019501-200609000-00005","volume":"17","author":"Andoh Y.","year":"2006","unstructured":"Andoh Y.; Fujii S.; Iwabuchi K.; Lower prevalence of circulating natural killer T cells in patients with angina: a potential novel marker for coronary artery disease. Coron Artery Dis 2006,17(6),523-528","journal-title":"Coron Artery Dis"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.intimp.2010.12.019","volume":"11","author":"Liu L.L.","year":"2011","unstructured":"Liu L.L.; Lu J.L.; Chao P.L.; Lin L.R.; Zhang Z.Y.; Yang T.C.; Lower prevalence of circulating invariant natural killer T (iNKT) cells in patients with acute myocardial infarction undergoing primary coronary stenting. Int Immunopharmacol 2011,11(4),480-484","journal-title":"Int Immunopharmacol"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/cvr\/cvy164","volume":"115","author":"Wang H.X.","year":"2019","unstructured":"Wang H.X.; Li W.J.; Hou C.L.; CD1d-dependent natural killer T cells attenuate angiotensin II-induced cardiac remodelling via IL-10 signalling in mice. Cardiovasc Res 2019,115(1),83-93","journal-title":"Cardiovasc Res"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000185078","volume":"49","author":"Asaka M.","year":"1988","unstructured":"Asaka M.; Iida H.; Izumino K.; Sasayama S.; Depressed natural killer cell activity in uremia. Evidence for immunosuppressive factor in uremic sera. Nephron 1988,49(4),291-295","journal-title":"Nephron"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1093\/ndt\/gfm596","volume":"23","author":"Vacher-Coponat H.","year":"2008","unstructured":"Vacher-Coponat H.; Brunet C.; Lyonnet L.; Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients. Nephrol Dial Transplant 2008,23(4),1406-1414","journal-title":"Nephrol Dial Transplant"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/ndt\/5.6.437","volume":"5","author":"Cala S.","year":"1990","unstructured":"Cala S.; Mazuran R.; Kordi\u0107 D.; Negative effect of uraemia and cuprophane haemodialysis on natural killer cells. Nephrol Dial Transplant 1990,5(6),437-440","journal-title":"Nephrol Dial Transplant"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/ki.1993.182","volume":"43","author":"Zaoui P.","year":"1993","unstructured":"Zaoui P.; Hakim R.M.; Natural killer-cell function in hemodialysis patients: effect of the dialysis membrane. Kidney Int 1993,43(6),1298-1305","journal-title":"Kidney Int"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0272-6386(96)90360-1","volume":"27","author":"Gascon A.","year":"1996","unstructured":"Gascon A.; Orfao A.; Lerma J.L.; Antigen phenotype and cytotoxic activity of natural killer cells in hemodialysis patients. Am J Kidney Dis 1996,27(3),373-379","journal-title":"Am J Kidney Dis"},{"key":"ref=165","first-page":"212","volume":"5","author":"D\u00f6ring Y.","year":"2014","unstructured":"D\u00f6ring Y.; Pawig L.; Weber C.; Noels H.; The CXCL12\/CXCR4 chemokine ligand\/receptor axis in cardiovascular disease. Front Physiol 2014,5,212","journal-title":"Front Physiol"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.117.027646","volume":"136","author":"D\u00f6ring Y.","year":"2017","unstructured":"D\u00f6ring Y.; Noels H.; van der Vorst E.P.C.; Vascular CXCR4 Limits Atherosclerosis by Maintaining Arterial Integrity: Evidence From Mouse and Human Studies. Circulation 2017,136(4),388-403","journal-title":"Circulation"},{"key":"ref=167","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170644","volume":"12","author":"Rowinska Z.","year":"2017","unstructured":"Rowinska Z.; Koeppel T.A.; Sanati M.; Role of the CX3C chemokine receptor CX3CR1 in the pathogenesis of atherosclerosis after aortic transplantation. PLoS One 2017,12(2)","journal-title":"PLoS One"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000350839","volume":"35","author":"Peraldi M.N.","year":"2013","unstructured":"Peraldi M.N.; Berrou J.; M\u00e9tivier F.; Toubert A.; Natural killer cell dysfunction in uremia: the role of oxidative stress and the effects of dialysis. Blood Purif 2013,35(Suppl. 2),14-19","journal-title":"Blood Purif"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1074\/jbc.M111.282152","volume":"287","author":"Lin D.","year":"2012","unstructured":"Lin D.; Lavender H.; Soilleux E.J.; O\u2019Callaghan C.A.; NF-\u03baB regulates MICA gene transcription in endothelial cell through a genetically in-hibitable control site. J Biol Chem 2012,287(6),4299-4310","journal-title":"J Biol Chem"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/ndt\/gft495","volume":"29","author":"Peukert K.","year":"2014","unstructured":"Peukert K.; Wingender G.; Patecki M.; Invariant natural killer T cells are depleted in renal impairment and recover after kidney transplantation. Nephrol Dial Transplant 2014,29(5),1020-1028","journal-title":"Nephrol Dial Transplant"}],"container-title":["Current Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/183220","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/183220\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/183220","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T16:46:41Z","timestamp":1626194801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/183220\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,4]]},"references-count":170,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570161118666200628024027","relation":{},"ISSN":["1570-1611"],"issn-type":[{"value":"1570-1611","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-01-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}